Evogene Ltd.
General ticker "EVGN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $7.8M (TTM average)
Evogene Ltd. does not follow the US Stock Market performance with the rate: -29.0%.
Estimated limits based on current volatility of 6.9%: low 0.57$, high 0.66$
Factors to consider:
- Total employees count: 192 as of 2013
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.59$, 2.04$]
- 2026-12-31 to 2027-12-31 estimated range: [0.80$, 2.45$]
Financial Metrics affecting the EVGN estimates:
- Positive: with PPE of -0.4 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of 221.11 > -0.60
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Inventory ratio change, % of -12.15 <= -0.75
Short-term EVGN quotes
Long-term EVGN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2.98MM | $5.58MM | $3.85MM |
| Operating Expenses | $25.21MM | $24.38MM | $17.89MM |
| Operating Income | $-22.23MM | $-18.80MM | $-14.03MM |
| Non-Operating Income | $0.28MM | $4.00MM | $0.54MM |
| Interest Expense | $0.17MM | $0.12MM | $1.89MM |
| R&D Expense | $16.20MM | $12.51MM | $7.99MM |
| Income(Loss) | $-21.95MM | $-14.81MM | $-13.50MM |
| Taxes | $0.02MM | $0.01MM | $0.00MM |
| Net Income(Loss)* | $-23.88MM | $-16.48MM | $-8.48MM |
| Stockholders Equity | $12.05MM | $-1.45MM | $-0.08MM |
| Inventory | $0.08MM | $1.82MM | $0.21MM |
| Assets | $51.10MM | $39.86MM | $20.05MM |
| Operating Cash Flow | $-21.58MM | $-19.70MM | $-13.50MM |
| Capital expenditure | $0.79MM | $0.63MM | $0.14MM |
| Investing Cash Flow | $-4.54MM | $9.62MM | $17.74MM |
| Financing Cash Flow | $18.15MM | $4.66MM | $-6.60MM |
| Earnings Per Share** | $-5.23 | $-2.89 | $-1.08 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.